Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.14 --0%
EPS Growth %: -195.2%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -195.2%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $78.89 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
- Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
